Suppression of tumor metastasis by manganese superoxide dismutase is associated with reduced tumorigenicity and elevated fibronectin

Oncology Reports

Volumn 4, Issue 4, 1997, Pages 753-757

  St Clair, Daret K ^a,b   Wan, X Steven ^a,c   Kuroda, Masahiro ^a,d   Vichitbandha, Satit ^a   Tsuchida, Emiko ^a   Urano, Muneyasu ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Fibronectin; MnSOD; Tumor metastasis; Tumor suppressor; Tumorigenicity

Indexed keywords

FIBRONECTIN; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; DNA DAMAGE; FIBROSARCOMA; GENETIC TRANSFECTION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030800124     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.4.753     Document Type: Article

References (33)

1. Weisiger RA and Fridovich I: Superoxide dismutase: Organelle specificity. J Biol Chem 248: 4793-4796, 1973.
2. Muse KE, Oberley TD, Sempf JM and Oberley LW: Immunolocalization of antioxidant enzymes in adult hamster kidney. Histochem J 26: 734-753, 1994.
3. Shigenaga MK, Hagen TM and Ames BN: Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91: 10771-10778, 1994.
4. Oberley LW and Buettner GR: Role of superoxide dismutase in cancer. A review. Cancer Res 39: 1141-1149, 1979.
5. Oberley LW and Oberley TD: Free radicals, cancer, and aging. In: Free radicals, Aging and Degenerative diseases. JE Johnson Jr. (ed). Alan R Liss, New York, pp325-372, 1986.
6. Oberley LW: Superoxide dismutase and cancer. Oncology Overview. NCI Monogram pp1-63, 1982.
7. St. Clair DK, Wan XS, Oberley TD, Muse KE and St. Clair WH: Suppression of radiation-induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase. Mol Carcinogenesis 6: 238-242, 1992.
8. St. Clair DK, Oberley TD, Muse KE and St. Clair WH: Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radic Biol Med 16: 275-282, 1994.
9. Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS and Trent J M: Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA 90: 3113-3117, 1993.
10. Li JJ, Oberley LW, St. Clair DK, Ridnour LA and Oberley TD: Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 10: 1989-2000, 1995.
11. Safford SE, Oberley TD, Urano M and St. Clair DK: Overexpression of manganese superoxide dismutase suppresses metastasis of fibrosarcoma. Cancer Res 54: 4261-4265, 1994.
12. Urano M, Kuroda M, Reynolds R, Oberley TD and St. Clair DK: Transfection of manganese superoxide dismutase cDNA reduces tumor control radiation dose: Gene-Radiotherapy. Cancer Res 55: 2490-2493, 1995.
13. Roos E: Cellular adhesion, invasion and metastasis. Biochim Biophys Acta 738: 263-284, 1984.
14. Schalken JA, Ebeling SB, Issacs JT, Treiger B, Bussemaker M, de Jong MEM and Van den Ven WJM: Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis. Cancer Res 48: 2042-2046, 1988.
15. Vaheri A, Keski-Oja J and Vartio T: Fibronectin and malignant transformation. In: Fibronectin, DF Mosher (ed.). Academic Press Inc., San Diego, pp255-271, 1989.
16. 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60: 849-859, 1990.
17. Wong GHW and Goeddel DV: Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science 242: 941-944, 1988.
18. Wong GHW, Elwell JH, Oberley LW and Goeddel DV: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58: 923-931, 1989.
19. Krall J, Bagley AC, Mullenbach GT, Hallewell RA and Lynch RE: Superoxide mediates the toxicity of paraquat for cultured mammalian cells. J Biol Chem 263: 1910-1914, 1988.
20. St. Clair DK, Oberley TD and Ho Y-S: Overproduction of human Mn-superoxide dismutase modulates paraquat-mediated toxicity in mammalian cells. FEBS Lett 293: 199-203, 1991.
21. Hirose K, Longo DL, Oppenheim JJ and Matsushima K: Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 7: 361-368, 1993.
22. Amstad P, Peskin A, Shah G, Mirault ME, Moret R, Zbinden I and Cerutti P: The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 30: 9305-9313, 1991.
23. Keiner MJ and Bagnell R: Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase, and glutathione transferase activity in cells transfected with copper-zinc superoxide dismutase expression vector. J Biol Chem 265: 10872-10875, 1990.
24. Kunda N, Zhang S and Fulton AM: Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastasis of murine mammary carcinoma. Clin Exp Metastasis 13: 16-22, 1995.
25. Delvin J and Harris H: Selective incorporation of fibronectin isoforms into the extracellular matrix of hybrids between human fibrosarcoma cells and normal human fibroblasts. Exp Cell Res 214: 429-432, 1994.
26. Chandler LA and Bourgeois S: Posttranscriptional down-regulation of fibronectin in N-ras-transformed cells. Cell Growth Diff 2: 379-384, 1991.
27. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K and Tryggvason K: Laminin-5 is a marker of invading cancer cells in some human carcinomas and in budding cancer cells in colon adenocarcinomas. Cancer Res 55: 4132-4139, 1995.
28. Kornblihtt AR, Umezawa K, Vibe-Pederson K and Baralle FE: Primary structure of human fibronectin: Differential splicing may generate at least 10 polypeptides from a single gene. EMBO J 4: 1755-1759, 1985.
29. Oliver N, Newby RF, Furcht LT and Bourgeois S: Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell 33: 287-296, 1983.
30. Gu H and Oliver N: Transcriptional repression of fibronectin gene expression in v-src transformation. Exp Cell Res 217: 428-439, 1995.
31. Dean DC, Bowlus CL and Bourgeois S: Cloning and analysis of the promoter region of the human fibronectin gene. Proc Natl Acad Sci USA 84: 1876-1880, 1987.
32. Knoepfel L, Steinkuhler C, Carri M-T and Rotilio G: Role of zinc-coordination and of the glutathione redox couple in the redox susceptibility of human transcription factor SP1. Biochem Biophys Res Comm 201: 871-877, 1994.
33. Ammendola R, Mesuraca M, Russo T and Cimino F: The DNA-binding efficiency of SP1 is affected by redox changes. Eur J Biochem 225: 483-489, 1994.